title: Novel 4-anilino-α-carboline derivatives induce cell death in nonadhesive breast cancer cells through inhibition of Brk activity.
authors.forename: Markus
authors.initials: M
authors.lastname: Oelze
authors.forename: Kazem Ahmed
authors.initials: KA
authors.lastname: Mahmoud
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Sippl
authors.forename: Tom
authors.initials: T
authors.lastname: Wersig
authors.forename: Andreas
authors.initials: A
authors.lastname: Hilgeroth
authors.forename: Christoph A
authors.initials: CA
authors.lastname: Ritter
mesh_terms: D000814:Aniline Compounds / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002243:Carbolines / Q000494:pharmacology*; D002448:Cell Adhesion; D045744:Cell Line, Tumor; D005260:Female; D006801:Humans; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors*; D010766:Phosphorylation; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D050796:STAT3 Transcription Factor / Q000378:metabolism
chemical_list: D000814:Aniline Compounds; D002243:Carbolines; D009363:Neoplasm Proteins; D050796:STAT3 Transcription Factor; D011505:Protein-Tyrosine Kinases; C088375:PTK6 protein, human